QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
Clinical trial NCT06951997 · RECRUITING
Trial details
- NCT number
- NCT06951997
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-07
- Primary completion
- 2027-05-15
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.